MedTrace Logo

CTC Detection Rate in SCCHN With a in Vivo Device

NCT03071900 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2017-03-07

No results posted yet for this study

Summary

Detection rate and isolation yield of CTC is low in squamous cell carcinoma of head and neck (SCCHN) with in vitro approaches rely on limited sample volumes. In this study, we applied a new method, the CellCollector, which could capture CTC in vivo from peripheral blood.

Conditions

  • Circulating Tumor Cell
  • Squamous Cell Carcinoma of the Head and Neck

Interventions

DIAGNOSTIC_TEST

circulating tumor cell analysis

Detect circulating tumor cells with CellCollector in SCCHN and control group.

Sponsors & Collaborators

  • Nanjing Tongren Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-22
Primary Completion
2017-03-15
Completion
2017-04-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03071900 on ClinicalTrials.gov